Mutagenicity of the non-carcinogenic dibenzylnitrosamine and an alpha-acetoxy derivative

Cancer Lett. 1979 Feb;6(2):83-7. doi: 10.1016/s0304-3835(79)80005-1.

Abstract

The mutagenicity of a non-carcinogenic nitrosamine, N,N-dibenzylnitrosamine (I), and a chemically synthesized alpha-acetoxy derivative, N-(alpha-acetoxy-benzyl)-N-benzylnitrosamine (II), has been examined in Salmonella typhimurium TA100 and TA1535. Compound (I) was non-mutagenic when tested directly or in the presence of a metabolic activation system while (II) was highly mutagenic when tested directly. This is the first report on the conversion of a non-mutagenic N-nitrosamine to a mutagen by the formation of an alpha-acetoxy derivative.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Benzyl Compounds / pharmacology
  • Biotransformation
  • Drug Evaluation, Preclinical / methods
  • In Vitro Techniques
  • Microsomes, Liver / metabolism
  • Mutagens* / metabolism
  • NADP / metabolism
  • Nitrosamines / metabolism
  • Nitrosamines / pharmacology*
  • Rats
  • Salmonella typhimurium / drug effects

Substances

  • Benzyl Compounds
  • Mutagens
  • Nitrosamines
  • NADP
  • N-nitrosodibenzylamine